
Samantha L. Shterengarts
Examiner (ID: 2, Phone: (571)270-5316 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 4131, 1623, 1626 |
| Total Applications | 2313 |
| Issued Applications | 1786 |
| Pending Applications | 96 |
| Abandoned Applications | 469 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11963510
[patent_doc_number] => 20170267662
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-21
[patent_title] => 'INDOLE COMPOUNDS AND PHARMACEUTICAL USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/337583
[patent_app_country] => US
[patent_app_date] => 2016-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 69077
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15337583
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/337583 | INDOLE COMPOUNDS AND PHARMACEUTICAL USE THEREOF | Oct 27, 2016 | Abandoned |
Array
(
[id] => 14652619
[patent_doc_number] => 20190233438
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-01
[patent_title] => NOVEL BICYCLIC HETEROCYCLIC COMPOUND
[patent_app_type] => utility
[patent_app_number] => 15/769835
[patent_app_country] => US
[patent_app_date] => 2016-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45725
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15769835
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/769835 | Bicyclic heterocyclic compound | Oct 20, 2016 | Issued |
Array
(
[id] => 13507643
[patent_doc_number] => 20180305364
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-25
[patent_title] => PRODRUGS OF IMIDAZOTRIAZINE COMPOUNDS AS CK2 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 15/769113
[patent_app_country] => US
[patent_app_date] => 2016-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16570
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 178
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15769113
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/769113 | Prodrugs of imidazotriazine compounds as CK2 inhibitors | Oct 18, 2016 | Issued |
Array
(
[id] => 11435992
[patent_doc_number] => 20170037013
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-09
[patent_title] => 'ANTIFUNGAL COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 15/297906
[patent_app_country] => US
[patent_app_date] => 2016-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8524
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15297906
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/297906 | Antifungal compound | Oct 18, 2016 | Issued |
Array
(
[id] => 17451796
[patent_doc_number] => 11266631
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-08
[patent_title] => Hodgkin lymphoma therapy
[patent_app_type] => utility
[patent_app_number] => 16/341089
[patent_app_country] => US
[patent_app_date] => 2016-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 29
[patent_no_of_words] => 13501
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16341089
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/341089 | Hodgkin lymphoma therapy | Oct 10, 2016 | Issued |
Array
(
[id] => 16168162
[patent_doc_number] => 10709702
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-14
[patent_title] => Treatment of skin disorders by topical administration of VEGF inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/766340
[patent_app_country] => US
[patent_app_date] => 2016-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 5983
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15766340
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/766340 | Treatment of skin disorders by topical administration of VEGF inhibitors | Oct 6, 2016 | Issued |
Array
(
[id] => 17843707
[patent_doc_number] => 11433047
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-06
[patent_title] => Pharmaceutical compositions comprising one or more pyrone compounds, and their use for treating inflammatory and neurodegenerative diseases
[patent_app_type] => utility
[patent_app_number] => 15/288780
[patent_app_country] => US
[patent_app_date] => 2016-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 27953
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15288780
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/288780 | Pharmaceutical compositions comprising one or more pyrone compounds, and their use for treating inflammatory and neurodegenerative diseases | Oct 6, 2016 | Issued |
Array
(
[id] => 16139591
[patent_doc_number] => 10702850
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-07
[patent_title] => Adsorbents with stepped isotherms for gas storage applications
[patent_app_type] => utility
[patent_app_number] => 15/766495
[patent_app_country] => US
[patent_app_date] => 2016-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 63
[patent_no_of_words] => 24271
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 301
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15766495
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/766495 | Adsorbents with stepped isotherms for gas storage applications | Oct 6, 2016 | Issued |
Array
(
[id] => 13425811
[patent_doc_number] => 20180264448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-20
[patent_title] => NI(0) CATALYSTS
[patent_app_type] => utility
[patent_app_number] => 15/763468
[patent_app_country] => US
[patent_app_date] => 2016-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8716
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -41
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15763468
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/763468 | Ni(0) catalysts | Sep 29, 2016 | Issued |
Array
(
[id] => 13522181
[patent_doc_number] => 20180312633
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-01
[patent_title] => LIPID DERIVATIVE IN WHICH HYDROPHILIC POLYMER IS BOUND THROUGH CYCLIC BENZYLIDENE ACETAL LINKER
[patent_app_type] => utility
[patent_app_number] => 15/764441
[patent_app_country] => US
[patent_app_date] => 2016-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14699
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15764441
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/764441 | Lipid derivative in which hydrophilic polymer is bound through cyclic benzylidene acetal linker | Sep 28, 2016 | Issued |
Array
(
[id] => 11663513
[patent_doc_number] => 20170152232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-01
[patent_title] => 'NITROGEN-CONTAINING AROMATIC HETEROCYCLIC COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 15/277484
[patent_app_country] => US
[patent_app_date] => 2016-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43262
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15277484
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/277484 | NITROGEN-CONTAINING AROMATIC HETEROCYCLIC COMPOUND | Sep 26, 2016 | Abandoned |
Array
(
[id] => 12086766
[patent_doc_number] => 09840485
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2017-12-12
[patent_title] => 'Bisfuran dihalide, method for producing bisfuran dihalide, and method for producing bisfuran diacid, bisfuran diol or bisfuran diamine using bisfuran dihalide'
[patent_app_type] => utility
[patent_app_number] => 15/277297
[patent_app_country] => US
[patent_app_date] => 2016-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7107
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15277297
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/277297 | Bisfuran dihalide, method for producing bisfuran dihalide, and method for producing bisfuran diacid, bisfuran diol or bisfuran diamine using bisfuran dihalide | Sep 26, 2016 | Issued |
Array
(
[id] => 17922754
[patent_doc_number] => 11465987
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-11
[patent_title] => Compounds for treatment of cancer
[patent_app_type] => utility
[patent_app_number] => 15/270359
[patent_app_country] => US
[patent_app_date] => 2016-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 49
[patent_figures_cnt] => 42
[patent_no_of_words] => 75680
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15270359
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/270359 | Compounds for treatment of cancer | Sep 19, 2016 | Issued |
Array
(
[id] => 15191183
[patent_doc_number] => 10493061
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-03
[patent_title] => Compositions and methods comprising 2-(acylamino)imidazoles
[patent_app_type] => utility
[patent_app_number] => 15/268410
[patent_app_country] => US
[patent_app_date] => 2016-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 40
[patent_no_of_words] => 39394
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15268410
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/268410 | Compositions and methods comprising 2-(acylamino)imidazoles | Sep 15, 2016 | Issued |
Array
(
[id] => 11514235
[patent_doc_number] => 20170081307
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-23
[patent_title] => 'HETEROARYL COMPOUNDS AS IRAK INHIBITORS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/267606
[patent_app_country] => US
[patent_app_date] => 2016-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39244
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15267606
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/267606 | Heteroaryl compounds as IRAK inhibitors and uses thereof | Sep 15, 2016 | Issued |
Array
(
[id] => 13399755
[patent_doc_number] => 20180251420
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-06
[patent_title] => METHOD FOR PREPARATION OF N-BUTYL NITRITE
[patent_app_type] => utility
[patent_app_number] => 15/747510
[patent_app_country] => US
[patent_app_date] => 2016-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2617
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15747510
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/747510 | Method for preparation of n-butyl nitrite | Sep 13, 2016 | Issued |
Array
(
[id] => 12106234
[patent_doc_number] => 09862705
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-09
[patent_title] => 'Salts of a pim kinase inhibitor'
[patent_app_type] => utility
[patent_app_number] => 15/260695
[patent_app_country] => US
[patent_app_date] => 2016-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 46
[patent_no_of_words] => 38712
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15260695
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/260695 | Salts of a pim kinase inhibitor | Sep 8, 2016 | Issued |
Array
(
[id] => 16042803
[patent_doc_number] => 10683260
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-16
[patent_title] => Crystalline form of sacubitril sodium salt
[patent_app_type] => utility
[patent_app_number] => 16/331088
[patent_app_country] => US
[patent_app_date] => 2016-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 3793
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16331088
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/331088 | Crystalline form of sacubitril sodium salt | Sep 6, 2016 | Issued |
Array
(
[id] => 16335582
[patent_doc_number] => 10786520
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-29
[patent_title] => Aminoglycoside derivatives and uses thereof in treating genetic disorders
[patent_app_type] => utility
[patent_app_number] => 15/756591
[patent_app_country] => US
[patent_app_date] => 2016-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 2
[patent_no_of_words] => 18096
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 208
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15756591
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/756591 | Aminoglycoside derivatives and uses thereof in treating genetic disorders | Sep 1, 2016 | Issued |
Array
(
[id] => 13399797
[patent_doc_number] => 20180251441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-06
[patent_title] => ION-ACTIVATED PHOTOLABILE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 15/756788
[patent_app_country] => US
[patent_app_date] => 2016-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19590
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15756788
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/756788 | Ion-activated photolabile compounds | Aug 31, 2016 | Issued |